Keros Therapeutics
KROS
KROS
163 hedge funds and large institutions have $2.03B invested in Keros Therapeutics in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 45 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 152 → 163 (+11)
5.82% more ownership
Funds ownership: 87.28% → 93.1% (+5.8%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
163
Holding in Top 10
5
Calls
$4.47M
Puts
$528K
Top Buyers
| 1 | +$33.5M | |
| 2 | +$30.5M | |
| 3 | +$19M | |
| 4 |
Alkeon Capital Management
New York
|
+$17.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$17.1M |
Top Sellers
| 1 | -$16M | |
| 2 | -$14.5M | |
| 3 | -$10.5M | |
| 4 |
Goldman Sachs
New York
|
-$9.63M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$6.92M |